Why the study?
Does detection of subclinical or early cardiovascular disease avert high risk in persons with diabetes?
Does detection of subclinical or early cardiovascular disease avert high risk in persons with diabetes?
This conference report discusses current data and recommendations for cardiovascular disease risk assessment in patients with diabetes.
Updated diabetes CVD risk assessment recommendations now inform practice; extends prior guidelines with integrated contemporary data.
Writing Group addressed whether the high risk associated with diabetes can be averted by detection of subclinical or early cardiovascular disease (CVD) that would enable earlier focused intervention. This article will discuss current data and recommendations for risk assessment of CVD in persons with diabetes.
No takes yet. Share an insight, caveat, or question.
Redberg et al. (2002) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: